ClinicalTrials.gg
RecruitingNCT02236351Updated Jun 22, 2023

New Pediatric Patching Method to Improve Compliance

An interventional study of Pinch Patch/ flat Patch in Amblyopia and Strabismus, sponsored by Baylor College of Medicine. Recruiting at 1 site in United States. Open to participants aged Up to 7 Years. Per ClinicalTrials.gov, last updated 2023-06-22.

Sponsored by Baylor College of Medicine · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Feb 2024, 2 years 9 months ago, but the record still lists the study as recruiting.
  • Registered 3 months after the study started (first participant enrolled Jun 2014, registered Sep 2014).
  • Started Jun 2014; still recruiting 12 years 5 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
200
Allocation
Randomized
Ages
Up to 7 Years
Sex
All
01

Study summary

This project will assess whether there is a significant difference in compliance with patching in amblyopic patients whose parents are instructed to pinch the superior and inferior edges of the patch before applying (in order to improve comfort) versus patients whose parents are instructed to place the patch evenly around the orbit.

Read the detailed description

Patients will present to the pediatric ophthalmology clinic at Texas Children's Hospital. If during the course of their standard care visit it is determined by their pediatric ophthalmologist or optometrist that patching is indicated and that the patient meets eligibility criteria for the study, the eye doctor will explain to the patient's parents the need for patching according to the standard protocol and will then mention to them the study being conducted. If they are interested, an investigator will explain the study, allow patients and parents to ask questions, and will then seek written informed consent. Upon consent, a patient will be assigned an ID code that will be written on their signed consent form. Consenting parents will then be randomized into either the control group (taught to apply the patch using the standard method) or the study group ( taught to apply the patch using our modified technique). The standard technique refers to applying the patch evenly and flatly around the orbit, and the modified technique refers to pinching the middle of the superior and inferior edges of the patch before applying so that the patch is convex and the center is raised above the eye in an attempt to improve patient comfort. All patients will be provided with one box of sample patches. In order to mask parents in both groups, these patches will all have a small incision of 3 millimeters on the lateral edges so that parents will be uncertain if they are assigned to the control or study group. An incision of this size will not significantly alter the function of the patch in any way. Patients will have equal odds of being assigned to either the control or study group using a random number generator. Parents will not be told whether the method they are being taught is the standard or modified method, and their eye doctor will not be told whether or not the parents decided to enroll in the study. After using one full box of patches or after one month, whichever comes first, parents will complete a questionnaire about their compliance with the prescribed patching regimen and any difficulties they may have had in patching their child. We will use the Amblyopia Treatment Index Patching Questionnaire designed by the Pediatric Eye Disease Investigator Group, with the addition of several questions related to patients' comfort while patching. Patients will be instructed to return for standard follow-up care as determined by their eye doctor.

02

Conditions studied

  • Amblyopia
  • Strabismus

Keywords

  • patching
  • pediatric ophthalmology
03

In context

Amblyopia

189 studies on the registry are indexed under Amblyopia; 41 are open to participants now.

This study's planned enrollment of 200 is above the median of 60 across 137 interventional studies indexed under Amblyopia.

Browse Amblyopia studies →

Lead sponsor

Baylor College of Medicine is the lead sponsor of 747 studies on the registry; 110 are open to participants now.

Of its 84 completed or terminated interventional studies of FDA-regulated products, 45 (54%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 7 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients prescribed an eye patch by a pediatric ophthalmologist or optometrist to treat either strabismus, anisometropia, or deprivation amblyopia
  • Patients aged from birth up to and including 7 years old

Exclusion criteria

Exclusion Criteria:

  • Known skin reaction to patch or bandage adhesive
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
200 participants (estimated)

Study arms

  • Placebo comparator
    Control

    Patients assigned to the Control Arm will be taught to apply their patches using the standard technique -- applying the patch evenly and flatly around the orbit.

    Device: Pinch Patch/ flat Patch

  • Experimental
    Pinched Patch

    Patients assigned to the Pinched Patch Arm will be taught to apply their patches after pinching the middle of the superior and inferior edges of the patch so that the patch is convex and the center is raised above the eye.

    Device: Pinch Patch/ flat Patch

Interventions

  • DevicePinch Patch/ flat Patch
06

What researchers measure

Primary outcomes

  1. Survey Responses

    Time frame: baseline

07

Study locations

1 of 1 sites recruiting
  • Texas Children's Hospital
    Houston, Texas 77030, United States
    Recruiting
    • Irene T Tung, MD · Contactirene.tung@bcm.edu · 832-822-3000
    • Gihan Romany · ContactGiha.Romany@bcm.edu · 832-822-3222
    • Michael A Puente, MS · Principal investigator
    • David K Coats, MD · Sub investigator
    • Jane C Edmond, MD · Sub investigator
    • Evelyn A Paysse, MD · Sub investigator
    • Mohamed A Hussein, MD · Sub investigator
    • Kimberly G Yen, MD · Sub investigator
    • Honey Herce, MD · Sub investigator
    • Amit R Bhatt, MD · Sub investigator
    • Mary K Kelinske, OD · Sub investigator
    • Candice Gardemal · Sub investigator
    • Miranda Freyre · Sub investigator
    • Christine Romero · Sub investigator
    • Kelsie B Morrison, OD · Sub investigator
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jun 2014 (actual). Primary completion is estimated for Feb 2024, 116 months after the start.

Of 58 non-industry interventional studies with no phase under Amblyopia, half reached primary completion within 34 months of starting (the median), counting those still running; a quarter within 21 and three quarters within 72. This study's planned 116 months is above that.

Counting every sponsor, half of 71 studies reached it within 33 months; a quarter within 17 and three quarters within 47.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 8, 2014
First posted
Sep 10, 2014
StartActual
Jun 2014
Primary completionEst.
Feb 2024
CompletionEst.
May 2024
Last update
Jun 22, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 22, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02236351
Responsible party
Irene Tintin Tung (Assistant Professor, TCH Ophthalmology, Baylor College of Medicine) — Principal investigator
First posted
Sep 10, 2014
Start date
Jun 2014
Primary completion
Feb 2024 (estimated)
Completion
May 2024 (estimated)
Last update
Jun 22, 2023
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion